The People's Insurance Company (Group) of China (1339) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
29 Apr, 2026Executive summary
Total operating income for Q1 2026 was RMB148,536 million, down 5.1% year-over-year.
Net profit attributable to owners was RMB8,814 million, a 31.4% decrease year-over-year.
Insurance revenue increased 2.0% to RMB138,881 million compared to Q1 2025.
The decline in profit was mainly due to lower investment returns amid capital market volatility.
Financial highlights
Profit before tax fell 42.7% year-over-year to RMB11,805 million.
Net cash flows from operating activities dropped 58.0% to RMB15,350 million.
Basic earnings per share was RMB0.20, down 31.4% year-over-year.
Weighted average return on equity decreased by 1.9 percentage points to 2.8%.
Total assets stood at RMB2,023,515 million, nearly flat from year-end 2025.
Outlook and guidance
The group aims to accelerate its transformation into a world-class insurance and financial group, focusing on high-quality development and stability.
Latest events from The People's Insurance Company (Group) of China
- Growth plans pair new insurance markets with health services and active investing.1339
Investor Day 2026 presentation - Revenue grew, profits and investment yield fell, while Life and Health NBV surged.1339
Q4 2023 - Higher insurance revenue and stronger P&C underwriting could not offset investment-driven profit declines.1339
Q3 2026 - Net profit surged 40.6% to RMB 50.8bn, with strong growth and a higher interim dividend.1339
Q2 2026 - Net profit rose 10% to RMB 62,451 million, with strong growth across all segments.1339
Q4 2025 - Quality-driven growth and global expansion define the future of non-auto insurance.1339
Investor Day 2025 Presentation - Net profit up 14.8% YoY to RMB 36,155m, with strong growth and a higher interim dividend.1339
Q2 2025 - Net profit up 13.7% to RMB23.4bn; insurance revenue up 6.0%; interim dividend proposed.1339
Q2 2024 - Net profit up 88.8% to RMB 42.2B, with robust growth and improved solvency ratios.1339
Q4 2024